Pharmaessentia Corp (6446 TT): Besremi Revenue Is Recovering; Fund Raising Through GDS Completed
Pharmaessentia reported record-high revenue of NT$509M for Jun’23, up 84% YoY and 22% MoM, driven by Besremi. The company raised $463M through GDS...
948 Views
ECM Weekly (23rd Apr 2023) - Rakuten Bank, Merdeka, ZJLD, Mankind, Lalatech, IMotion, Anta, KIT
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
627 Views
ECM Weekly (16th Apr 2023) - Rakuten Bank, Harita Nickel, Merdeka Battery, ZJLD, Adicon, Supcon
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
534 Views
PharmaEssentia GDS Issuance - Strong Revenue Growth and Narrowing Losses
Pharmaessentia Corp (6446 TT) aims to raise around US$412m (TWD12.6bn) via a GDS issuance. In this note, we will talk about the deal dynamics and...
1.2k Views
Pharmaessentia Corp (6446 TT): Besremi Starts 2023 on Strong Note; Geography Expansion Continues
Pharmaessentia reported 259% YoY revenue growth in January, driven by strong uptake of Besremi in US. The drug is expected to receive approvals in...
908 Views